Cryoprotectants are the basis for research on cryopreservation of various human cells, tissues, and organs. Since the discovery of the cryoprotective effect of glycerol in the 1960s, more than 50 drugs or reagents have been used for cryoprotection. In recent years, with the development of vitrification technology, in-depth research on cryoprotectants has attracted the attention of many researchers.
The cryopreservation of biological sample tissues usually includes two types: subnormal temperature preservation of 2 to 10°C and deep cryopreservation of -80 to -196°C. Subnormal temperature storage of 2 to 10°C is usually suitable for tissues and organs that can be transplanted or transported in a short time. Commonly used protective solutions include UW solution developed by the University of Wisconsin and has been clinically used for nearly 20 years, and was studied by Georges Lopez of France. The developed IGL solution, a low-potassium, low-sodium, non-body fluid HTK preservation solution, combines the advantages of UW solution and HTK solution, and is used in Celsior solution (CS solution) for cardiac preservation. Several cryopreservation solutions with relatively good effects, such as SMO solution (Shanghai Multi-Organ Preservation Solution), have also been developed in China. In addition, there are EC fluids that are widely used in Europe for standard preservation of clinical kidney transplants, and HC-A fluids that are mainly used for lavage and cryopreservation of organ transplants in China.
With the advancement of science and technology and the increasing demand for long-term preservation of samples, cryopreservation has become the only choice for cell, tissue and organ preservation research. Currently, liquid nitrogen cryopreservation has widely become the best way to preserve various cells and tissues. Way.
Cryoprotectants can be divided into two categories based on their role in cryogenic preservation: permeable and non-permeable protectants. Penetration protective agents are mainly polyols, including ethylene glycol (EG), dimethyl sulfoxide (DMSO), propylene glycol, glycerol, formamide and acetamide, etc. The role of osmotic protectants is to reduce or avoid the formation of intracellular ice crystals by lowering the freezing point and replacing the water around intracellular proteins, DNA and other components. Non-permeable protective agents mainly include low molecular weight monosaccharides (fructose, glucose, maltose, etc.), disaccharides (sucrose, trehalose, etc.), polysaccharides (raffinose, etc.) and polymer compounds with a molecular weight greater than 1000 Da ( Polysucrose, dextran, polyvinylpyrrolidone, polyethylene glycol, polyvinyl alcohol and hydroxyethyl starch, etc.). The non-permeable protective agent is beneficial to improving the vitrification properties of the protective solution and improving the cryoprotective effect. At the same time, it promotes cell dehydration through osmosis, stabilizes the cell membrane, and reduces the amount of cryoprotectant required to achieve vitrification itself, thus reducing the vitrification solution. toxicity.
Ice blockers, antifreeze proteins, magnetic nanoparticles, and even some Chinese herbal ingredients (such as ginsenosides) and other new substances that are different from the above two categories have also been documented to have good cryoprotective effects. Conduct systematic analysis of the above various substances, screen appropriate combinations of cryoprotective substances according to the properties and requirements of different cryoprotection biological samples, and use advanced instruments and technical means to conduct parameter determination, cooling and recovery procedures screening to protect biological samples from ice crystals Damage, thereby providing good biological samples for clinical and basic scientific research, has become a new research direction.
In addition, on the basis of the research and development of existing protective agents, we should also actively pay attention to some other substances with potential application value, such as antioxidants (propyl citrate, vitamin E, vitamin C, amino acids, lecithin, protein hydrolysates, Sodium thiosulfate, sodium ascorbate), etc., finding alternative ingredients for commonly used toxic protective substances such as DMSO, and developing low-toxic or even non-toxic cryoprotectants is also an important research direction for us.
On the basis of the existing deep cryopreservation of various cells, more protective substances are selected and optimized, combined with new substances such as antifreeze proteins and nanomagnetic particles, and appropriate cooling and rewarming procedures are selected to achieve the preservation of samples such as clinical tissues and organs. High quality preservation.
On August 23, the Jinan Private Economic Development Bureau and China Economic Weekly jointly launched the theme publicity activity of "Central Media Look at Jinan - Entering Jinan's Private Economy" in Yinfeng Biotechnology Park.
Led by Anhui Medical University and participated by Yinfeng Cryogenic Medical Technology Co., Ltd., the "Engineering Research Center for Life Resources Conservation and Artificial Organs of the Ministry of Education" was officially accepted and awarded by the Ministry of Education. As one of the four major platforms for the transformation of the center's project, Yinfeng Cryogenic Co., Ltd. is responsible for the "development, promotion and application of cryogenic preservation technology of biological matrix materials".
On March 28, 2023, the kick-off meeting of the International Alliance for Life Extension Research was held in Jinan, Shandong. The "International Alliance for Life Extension Research" was initiated by Shandong Yinfeng Life Science Research Institute, and jointly established by 13 international scientific research institutions engaged in the field of cryogenic biomedicine from North America, Europe, Oceania, etc., and appeared at the conference through online and offline forms.